Hi ECT RepAlthough I really appreciate your response and...

First 42 Last

Share
Profile

Follow
aboutus

100 Posts.

100

28/05/19

11:41

Post #: 38777604
Share

Originally posted by ECT_Rep: ↑

D3008 and aboutus,
As you have noted, we have to walk a fine line between divulging every detail that interests shareholders and prospective investors. However, some of the information if divulged may be counter-productive to our commercial interests so we cannot inform you of every contingency plan based on the multiple outcomes.
Part of the difficulty in providing this type of feedback is two-fold:
a) dealing with the anonymity of trolls and working out whats a legitimate questions and whats baiting or flaming.
b) setting expectations with the HotCopper community that we should be accountable to answering all questions. From a commercial perspective this is not adviseable.

We do our best by opening up these sessions and try and fill in some of the questions that may be lingering and we genuinely appreciate the effort that most posters take in asking legitimate questions.

We'll keep holding these sessions but don't be offended if some of your questions cant ne answered and or are not available at the time you ask them. We also have to be mindful of the time the ECT_rep takes in responding to these questions.

Expand

Hi ECT Rep

Although I really appreciate your response and understand level of complexity, effort and time involved in Q&A session, however on some occasions it is necessary PR process, specially if some of the past announcements are not exactly in line with reality we were all exposed to with the associated consequences.

Thank you for your effort

AIMO

ECT Price at posting: 1.3¢ Sentiment: Hold Disclosure: Held
2 Upvote

1 Great analysis

Reply

Top Stories

3 stocks with antimony news on Thursday

CU6

Clarity progresses SECuRE trial with positive safety results

GTR

GTI extends uranium mineralisation at Lo Hema through development drilling

CHN

Chalice jumps on Putin nickel export ban threat – but then there's bad news

DXB

Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3